Oligo(ethylene glycol) derivatives of thioflavin T as inhibitors of protein-amyloid interactions

ChemBioChem

Volumn 7, Issue 10, 2006, Pages 1563-1566

  Inbar, Petra ^a   Li, Cui Q ^a   Takayama, Stacy A ^a   Bautista, Mahealani R ^a   Yang, Jerry ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amyloid fibrils; Catalase; Inhibitors; Proteins; Thioflavin T

Indexed keywords

2 (4 AMINOPHENYL)BENZOTHIAZOLE DERIVATIVE; 3 HYDROXYACYL COENZYME A DEHYDROGENASE; ALCOHOL DEHYDROGENASE; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; BENZOTHIAZOLE DERIVATIVE; CATALASE; ETHYLENE GLYCOL; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; PROTEIN DERIVATIVE; THIOFLAVINE; UNCLASSIFIED DRUG;

ANTIGEN BINDING; ARTICLE; BLOOD BRAIN BARRIER; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION;

AMYLOID BETA-PEPTIDES; AMYLOID BETA-PROTEIN; CATALASE; ETHYLENE GLYCOL; FLUORESCENT DYES; HUMANS; MOLECULAR STRUCTURE; POLYMERS; PROTEIN BINDING; PROTEINS; THIAZOLES;

EID: 33749675670     PISSN: 14394227     EISSN: 14397633     Source Type: Journal    
DOI: 10.1002/cbic.200600119     Document Type: Article

References (37)

1. K. Takuma, J. Yao, J. Huang, H. Xu, X. Chen, J. Luddy, A.-C. Trillat, D. M. Stern, O. Arancio, S. S. Yan, FASEB J. 2005, 19, 597-598.
2. P. Inbar, J. Yang, Bioorg. Med. Chem. Lett. 2006, 16, 1076-1079.
3. a) S. D. Yan, Y. Shi, A. Zhu, J. Fu, H. Zhu, Y. Zhu, L. Gibson, E. Stern, K. Collison, F. Al-Mohanna, S. Ogawa, A. Roher, S. G. Clarke, D. M. Stern, J. Biol. Chem. 1999, 274, 2145-2156;
4. b) S. D. Yan, J. Fu, C. Soto, X. Chen, H. Zhu, F. Al-Mohanna, K. Collison, A. Zhu, E. Stern, T. Saido, M. Tohyama, S. Ogawa, A. Roher, D. Stern, Nature 1997, 389, 689-695;
5. c) S. D. Yan, A. Roher, M. Chaney, B. Zlokovic, A. M. Schmidt, D. Stern, Biochim. Biophys. Acta 2000, 1502, 145-157.
6. a) S. D. Yan, D. M. Stern, Int. J. Exp. Pathol. 2005, 86, 161-171;
7. b) C. R. Kissinger, P. A. Rejto, L. A. Pelletier, J. A. Thomson, R. E. Showalter, M. A. Abreo, C. S. Agree, S. Margosiak, J. J. Meng, R. M. Aust, J. Mol. Biol. 2004, 342, 943-952.
8. a) N. G. N. Milton, N. P. Mayor, J. Rawlinson, Neuroreport 2001, 12, 2561-2566;
9. b) N. G. N. Milton, Biochem. J. 1999, 344, 293-296.
10. J. W. Lustbader, M. Cirilli, C. Lin, H. W. Xu, K. Takuma, N. Wang, C. Caspersen, X. Chen, S. Pollak, M. Chaney, F. Trinchese, S. Liu, F. Gunn-Moore, L.-F. Lue, D. G. Walker, P. Kuppusamy, Z. L. Zewier, O. Arancio, D. Stern, S. S. Yan, H. Wu, Science 2004, 304, 448-452.
11. a) L. Di, E. H. Kerns, Curr. Opin. Chem. Biol. 2003, 7, 402-408;
12. b) M. H. Abraham, Eur. J. Med. Chem. 2004, 39, 235-240.
13. W. E. Klunk, Y. Wang, G.-F. Huang, M. L. Debnath, D. P. Holt, C. A. Mathis, Life Sci. 2001, 69, 1471-1484.
14. a) C. Solbach, M. Uebele, G. Reischl, H.-J. Machulla, Appl. Radiat. Isot. 2005, 62, 591-595;
15. b) Y. Wang, W. E. Klunk, G.-F. Huang, M. L. Debnath, D. P. Holt, C. A. Mathis, J. Mol. Neurosci. 2002, 19, 11-16;
16. c) W. E. Klunk, Y. Wang, G.-f. Huang, M. L. Debnath, D. P. Holt, L. Shao, R. L. Hamilton, M. D. Ikonomovic, S. T. DeKosky, C. A. Mathis, J. Neurosci. 2003, 23, 2086-2092.
17. C. A. Mathis, Y. Wang, W. E. Klunk, Curr. Pharm. Des. 2004, 10, 1469-1492.
18. A. Lockhart, L. Ye, D. B. Judd, A. T. Merritt, P. N. Lowe, J. L. Morgenstern, G. Hong, A. D. Gee, J. Brown, J. Biol. Chem. 2005, 280, 7677-7684.
19. We defined 0 and 100% inhibition as the UV/Vis signals observed when the assay is run in the absence of small molecules and in the absence of both amyloid fibrils and small molecules, respectively.
20. U. C. T. Oppermann, S. Salim, L. O. Tjernberg, L. Terenius, H. Jornvall, FEBS Lett. 1999, 451, 238-242.
21. A. J. Powell, J. A. Read, M. J. Banfield, F. Gunn-Moore, S. D. Yan, J. Lustbader, A. R. Stern, D. M. Stern, R. L. Brady, J. Mol. Biol. 2000, 303, 311-327.
22. E. A. C. Wiemer, R. Ofman, E. Middelkoop, M. De Boer, R. J. A. Wanders, J. M. Tager, J. Immunol. Methods 1992, 151, 165-175.
23. R. J. Marttila, M. Roytta, H. Lorentz, U. K. Rinne, J. Neural Transm. 1988, 74, 87-95.
24. C. D. Putnam, A. S. Arvai, Y. Bourne, J. A. Tainer, J. Mol. Biol. 2000, 296, 295-309.
25. M. A. Lovell, W. D. Ehmann, S. M. P. Butler, W. R. Markesbery, Neurology 1995, 45, 1594-1601.
26. a) C. Behl, J. B. Davis, R. Lesley, D. Schubert, Cell 1994, 77, 817-827;
27. b) Z. Zhang, R. E. Rydel, G. J. Drzewiecki, K. Fuson, S. Wright, M. Wogulis, J. E. Audia, P. C. May, P. A. Hyslop, J. Neurochem. 1996, 67, 1595-1606.
28. P. E. Fraser, L. K. Duffy, M. B. O'Malley, J. Nguyen, H. Inouye, D. A. Kirschner, J. Neurosci. Res. 1991, 28, 474-485.
29. J. Frackowiak, B. Mazur-Kolecka, W. Kaczmarski, D. Dickson, Brain Res. 2001, 907, 44-53.
30. L. Li, T. A. Darden, L. Bartolotti, D. Kominos, L. G. Pedersen, Biophys. J. 1999, 76, 2871-2878.
31. G. Y. Wen, S. Y. Yang, W. Kaczmarski, X. Y. He, K. S. Pappas, Brain Res. 2002, 954, 115-122.
32. C. A. Lipinski, F. Lombardo, B. W. Dominy, P. J. Feeney, Adv. Drug Delivery Rev. 1997, 23, 3-25.
33. W. P. Walters, A. A. Murcko, M. A. Murcko, Curr. Opin. Chem. Biol. 1999, 3, 384-387.
34. a) D. E. Clark, J. Pharm. Sci. 1999, 88, 815-821;
35. b) J. Kelder, P. D. J. Grootenhuis, D. M. Bayada, L. P. C. Delbressine, J.-P. Ploemen, Pharm. Res. 1999, 16, 1514-1519.
36. P. Ertl, B. Rohde, P. Selzer, J. Med. Chem. 2000, 43, 3714-3717.
37. The uptake of these molecules in the brain has yet to be determined.